ArticleBMC public health2025
Cervical cancer screening uptake in Côte d'Ivoire: Analysis of prevalence and associated factors.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and determinants of cervical cancer screening among women aged 30-49 years in Nigeria: A population-based cross-sectional study.PLOS global public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical cancer is a major public health concern that affects millions of women worldwide. Screening for cervical cancer is one of the preventive interventions. However, cervical cancer screening uptake is low in sub-Saharan African countries. This study examined the prevalence of cervical cancer screening and its associated factors among women of reproductive age in Côte d'Ivoire.
methodsA weighted sample of 6,855 women aged 30-49 years was drawn from the 2021 Demographic and Health Survey (DHS) of Côte d'Ivoire. The DHS used a cross-sectional design, and respondents were sampled using a multistage cluster sampling technique. Percentages with confidence intervals (CIs) were used to summarise cervical cancer screening uptake. We used multilevel binary logistic regression analysis to examine the factors associated with cervical cancer screening uptake. Stata 18 was used for all the analyses and statistical significance was set at p < 0.05.
resultsThe proportion of women screened for cervical cancer was 7.7% [6.4, 9.3]. The odds of cervical cancer screening uptake increased with increasing levels of education, with the highest odds among women with higher education [adjusted odds ratio (aOR) = 2.34; 95% CI = 1.14, 4.79]. Women covered by health insurance [aOR = 2.63; 95% CI = 1.48, 4.69] and those who had visited a health facility in the last 12 months before the survey [aOR = 1.83; 95% CI = 1.27, 2.65] were more likely to be screened for cervical cancer compared to their counterparts who were uninsured and those without a history of health facility visits, respectively. Also, the odds of cervical cancer screening uptake increased with an increasing wealth index, with the highest odds among those in the richest wealth quintile [aOR = 4.67; 95% CI = 1.66, 13.12].
conclusionsCervical cancer screening uptake was low in Côte d'Ivoire. To achieve Sustainable Development Goal 3, health authorities, policymakers, and other stakeholders could implement strategies to scale up uptake. The identified associated factors could aid in the development of cervical cancer screening interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.